School of Breast Oncology® Live Video Webcast: Clinical Updates From San Antonio

12/15/2022

Register Now

December 15, 2022  12:30 pm - 2:30 pm ET

Overview

Each year, major international meetings provide valuable information on practice-changing clinical information from randomized phase III trials as well as emerging novel agents. This is equally true for the hundreds of smaller trials and sub-studies that, while not garnering the national attention of many phase III trials, still provide valuable clinical information. However, many practicing oncologists are unable to attend these meetings, and may be challenged to understand and process new clinical trial information in a manner that allows for optimal application to their practices.

This virtual symposium brings together renowned experts in the diagnosis and treatment of breast cancer to provide a comprehensive overview of noteworthy data presented during the San Antonio Breast Cancer Symposium, held in San Antonio, Texas, in December 2022. This webcast is an interactive program in which faculty discuss and debate the clinical implications and applications of emerging data and the future directions of breast cancer management. Topics include current and emerging treatment options for patients with early-stage and metastatic disease as well as locoregional control using surgery and radiation. This webcast, an extension of the annual School of Breast Oncology®, provides an additional forum for clinicians to keep pace with rapidly emerging data and advancing treatment paradigms in breast cancer.

Benefits of Attending

  • Review the latest data on current and emerging treatments for patients with breast cancer across the disease continuum.
  • Gain insights into how experts plan to apply emerging clinical data to their practices.
  • Expand your ability to integrate practice-changing data into individualized treatment decision-making

Target Audience

This educational activity is directed toward medical oncologists, surgical oncologists, radiation oncologists, nurses, and other healthcare professionals who treat patients with breast cancer.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Determine potentially practice changing efficacy and safety findings from recent clinical trials conducted in early and advanced breast cancer settings
  • Describe how recent evidence should be considered in the context of evolving treatment paradigms in breast cancer management and/or how these findings can be incorporated into clinical practice
  • Explain how ongoing clinical trials and their designs are intended to move the field forward and bridge clinically unmet needs in breast cancer care